Scientists unveil more than 600 new tissue models of human cancer
Derived from patient tumor samples and available to researchers around the world, the cells will aid the development of new cancer treatments.
Derived from patient tumor samples and available to researchers around the world, the cells will aid the development of new cancer treatments.
MIT researchers have found that a ketogenic high-fat, low-carbohydrate diet fuels the growth of intestinal tumors.
The new technology, which generates high-resolution, 3D images of breast tissue, requires no expertise to operate and could be used at home.
Cell biologist Whitney Henry and immunologist Harikesh Wong will receive four years of flexible funding to advance early-career research on ferroptosis and immune decision-making.
From Boston to Moscow and across the U.S., Harriet Latham Robinson SM ’61, PhD ’65 has balanced an exciting career at the forefront of molecular biology with family, friends, and adventure.
MIT researchers have designed an ultrasound system that creates a real-time 3D representation of the object being imaged.
Using a catheter coated with carbon nanotubes, researchers can detect biomarkers produced by cancer cells in the bladder.
Computational neuroscientist Sven Dorkenwald and cell biologist Whitney Henry, along with two MIT alumni, are recognized for their exceptional early-career research contributions.
Researchers can now use custom-built microscopy and nanotechnology to tag and follow the activity of individual proteins in real-time.
The MIT Marble Center for Cancer Nanomedicine looks back at 10 years of turning big ideas about nanotechnology into transformative advances for cancer patients.
Using immune-remodeling mRNA molecules, researchers generated T cells that can slow tumor growth and, in some cases, eradicate tumors.
A new study suggests that the chemical NDMA is much more likely to cause cancerous mutations after exposure early in life.
Long thought to be mainly a structural support, the cell membrane also influences how cells respond to signals and may contribute to the growth of cancer cells.
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
As an aspiring physician-scientist and editor-in-chief of The Tech, MIT senior Alex Tang has found inspiration in the lives of patients and others in his community.